Skip to main content

Table 5 Cox-proportional hazard models for major adverse cardiac event

From: A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions

 

HR

95% CI

p-value

Univariate

 Age > 65 years

1.29

0.517–3.237

0.58

 Men

1.21

0.434–3.367

0.72

 Current smoking

1.55

0.596–4.012

0.37

 Hypertension

4.04

0.931–17.527

0.06

 Diabetes mellitus

0.53

0.201–1.400

0.20

 Prior MI history

1.94

0.749–5.036

0.17

 NSTEMI/STEMI at index PCI

0.89

0.290–2.736

0.84

 LDL-C > 70 mg/dL

0.88

0.333–2.329

0.80

 eGFR < 60 ml/min/1.73m2

1.05

0.348–3.175

0.93

 LVEF < 40%

1.85

0.412–8.255

0.42

 Previous LMB lesion

1.89

0.620–5.735

0.26

 Previous 1st generation DES

1.46

0.582–3.657

0.42

 Stent-in-stent

0.53

0.122–2.335

0.40

 True bifurcation

3.88

1.545–9.743

< 0.01

 ISR type (III, IV)

1.16

0.471–2.871

0.74

 DCB (vs. DES)

1.64

0.595–4.509

0.34

Multivariate

 True bifurcation

4.53

1.476–13.898

< 0.01

  1. 95% CI 95% confidence interval; DCB drug-coated balloon; DES drug-eluting stent; eGFR estimated glomerular filtration rate; HR hazard ratio; ISR in-stent restenosis; LDL-C low density lipoprotein cholesterol; LVEF left ventricular ejection fraction; NSTEMI non-ST segment elevation myocardial infarction; STEMI ST segment elevation myocardial infarction
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us